Filtros de búsqueda

Lista de obras de Jan Walewski

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

artículo científico publicado en 2010

A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration

artículo científico publicado en 2018

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

artículo científico publicado en 2008

A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention

artículo científico publicado en 2020

A survey of prognostic value of serum factors in multiple myeloma patients before treatment: macrophage-colony stimulating factor (M-CSF) is a powerful predictor of survival

scientific article published on 31 December 2009

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

artículo científico publicado en 2016

Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients

artículo científico publicado en 2012

Aggressive B-cell lymphoma: chasing the target

scientific article published on 30 October 2019

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

artículo científico publicado en 2002

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

artículo científico publicado en 2013

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

artículo científico publicado en 2015

Bendamustine as monotherapy and in combination regimens for the treatment of chronic lymphocytic leukemia and non-hodgkin lymphoma: a retrospective analysis

artículo científico publicado en 2013

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

artículo científico publicado en 2011

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial

artículo científico publicado en 2012

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

artículo científico publicado en 2017

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

artículo científico

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

artículo científico publicado en 2017

Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial

Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study

scientific article published on 01 March 2020

CHOP-21 for unfavorable Hodgkin's lymphoma. An exploratory study.

artículo científico publicado en 2009

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

artículo científico publicado en 2006

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

artículo científico publicado en 2011

CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

scientific article published on 01 August 2000

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

artículo científico publicado en 2004

Causes of death in patients with non-Hodgkin's lymphoma

artículo científico publicado en 1988

Causes of death of patients with breast cancer treated at the Institute of Oncology in Warsaw in the years 1947-1970

artículo científico publicado el 1 de abril de 1977

Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

artículo científico publicado en 2016

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network

artículo científico publicado en 2013

Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium

scientific article published on 20 November 2019

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

artículo científico publicado en 2007

Chronic lymphocytic leukaemia presenting with central nervous system involvement

artículo científico publicado en 1999

Comparision of benefits of early, delayed, and no administration of G-CSF after autologous peripheral blood stem cell transplantation in lymphoma patients.

artículo científico publicado en 2013

Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).

artículo científico publicado en 2005

Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network

artículo científico publicado en 2014

Current Treatment of Chronic Lymphocytic Leukemia.

artículo científico publicado en 2017

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

artículo científico publicado en 2016

Developing a European network for adult ALL

scientific article published on 01 January 2004

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2012

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

artículo científico publicado en 2015

Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma.

artículo científico publicado en 2012

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

artículo científico publicado en 2006

ESMO Consensus Conference on malignant lymphoma: management of 'ultra-high-risk' patients

artículo científico publicado en 2018

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL).

artículo científico publicado en 2012

EZH2 Expression in Follicular Lymphoma Is Variable and Independent from the Progression of Disease Within 24 Months of First Treatment

artículo científico publicado en 2020

Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphoma

artículo científico publicado en 2011

Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells

scientific article published on 01 January 1989

Experience with autologous bone marrow harvesting and transfusion of marrow-derived red cells

artículo científico publicado el 1 de marzo de 1992

FcγRIIA and FcγRIIIA polymorphisms do not influence survival and response to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy in patients with diffuse large B-cell lymphoma

artículo científico publicado en 2011

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

artículo científico publicado en 2008

First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.

artículo científico publicado en 2019

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

artículo científico publicado en 2018

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods.

artículo científico publicado en 2006

Frequent aberrations of chromosome 8 in aggressive B-cell non-Hodgkin lymphoma

artículo científico

Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.

artículo científico publicado en 2014

High Prevalence of Genetically Related Clostridium Difficile Strains at a Single Hemato-Oncology Ward Over 10 Years

artículo científico publicado en 2020

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

artículo científico publicado en 2002

Higher genome variability within metabolism genes associates with recurrent Clostridium difficile infection

artículo científico publicado en 2021

Human regulatory T cells suppress proliferation of B lymphoma cells.

artículo científico publicado en 2016

Immunogenicity of influenza vaccination in patients with non-Hodgkin lymphoma

artículo científico publicado en 2007

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care

scientific article published on January 2009

Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial

artículo científico publicado en 2014

Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

artículo científico publicado en 2020

In memoriam: Professor Olga Mioduszewska

artículo científico publicado en 2018

Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation.

artículo científico publicado en 2013

Is Good Clinical Practice Becoming Poor Clinical Care?

artículo científico publicado en 2017

Lenalidomide potentiates CD4+CD25+Treg-related suppression of lymphoma B-cell proliferation.

artículo científico publicado en 2016

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

artículo científico publicado en 2016

Low-dose continuous chemotherapy (LBCMVD-56) for refractory and relapsing lymphoma

scientific article published on 01 July 2000

Mantle cell lymphoma presenting with paraproteinemia.

artículo científico publicado en 2005

Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning

article

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

artículo científico publicado en 2009

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2017

Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2014

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients

artículo científico publicado en 2004

Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia

artículo científico publicado en 2002

PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma

artículo científico publicado en 2020

Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement

artículo científico publicado en 2010

Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study

artículo científico publicado en 2020

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma

artículo científico publicado en 2019

Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs

artículo científico publicado en 2021

Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study

artículo científico publicado en 2010

Plasma alemtuzumab levels in patients with chronic lymphocytic leukemia treated with alemtuzumab combined with chemotherapy reflect the efficacy of the treatment: a hypothesis

artículo científico publicado en 2013

Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma

artículo científico publicado en 2016

Polymorphisms of DNA repair and oxidative stress genes in B-cell lymphoma patients

artículo científico publicado en 2012

Population-based epidemiological data of follicular lymphoma in Poland: 15 years of observation

artículo científico publicado en 2020

Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma

artículo científico publicado en 2008

Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study

artículo científico publicado en 2010

Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy

artículo científico publicado en 2020

Primary refractory multiple myeloma: a real-world experience with 85 cases

artículo científico publicado en 2020

Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma.

artículo científico publicado en 2010

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial G

article

Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy

artículo científico publicado en 2018

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

artículo científico publicado en 2017

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

artículo científico publicado en 2016

Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research

artículo científico publicado en 2008

Recovery of dendritic cell counts and function in peripheral blood of cancer patients after chemotherapy

artículo científico publicado en 2002

Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study

scientific article published on 30 August 2018

Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.

artículo científico publicado en 2001

Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

artículo científico publicado en 2013

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial

artículo científico publicado en 2014

Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group

artículo científico publicado en 2015

Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study

artículo científico publicado en 2008

Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma

artículo científico publicado en 2011

Significance of CD10 protein expression in the diagnostics of follicular lymphoma: A comparison of conventional immunohistochemistry with flow cytometry supported by the establishment of BCL2 and BCL6 rearrangements

artículo científico publicado en 2020

Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia.

artículo científico publicado en 2017

Stanowisko polskich ekspertów dotyczące zastosowania leku brentuksymab vedotin w leczeniu chorych na pierwotne chłoniaki skóry CD30+

artículo científico publicado en 2018

Tactical problems in the treatment of non-Hodgkin's lymphoma. I. Diagnosis

artículo científico publicado el 1 de octubre de 1979

The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.

artículo científico publicado en 2016

The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute

artículo científico publicado en 2015

The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplant

scientific article published on 10 September 2007

The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study

artículo científico publicado en 2017

Tolerability and efficacy of GM-CSF [Leucomax] in patients with small cell lung cancer treated with intensive chemotherapy

artículo científico publicado en 1996

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

artículo científico publicado en 2015

Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

artículo científico publicado en 2017

Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.

artículo científico publicado en 2004

Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial

scientific article published on 05 December 2019

Treatment of older patients with mantle-cell lymphoma.

artículo científico publicado en 2012

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

artículo científico publicado en 2012

Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas

artículo científico publicado en 2019

Two autologous transplants in the treatment of patients with Hodgkin's lymphoma: analysis of prognostic factors and comparison with a single procedure

scientific article published on 01 March 2007

Unusual IgD+/CD38-follicular lymphoma with leukemic presentation

artículo científico publicado en 2006

Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

artículo científico publicado en 2006

Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network

artículo científico

Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients

scientific article published on 09 March 2007

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2015

artículo científico publicado en 2015

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2016

artículo científico publicado en 2016

Zalecenia Polskiej Grupy Szpiczakowej dotyczące rozpoznawania i leczenia szpiczaka plazmocytowego oraz innych dyskrazji plazmocytowych na rok 2017

artículo científico publicado en 2017

[Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish lymphoma research group]

artículo científico publicado en 2003

[Malignant lymphoma (non-Hodgkin's)--principles of oncological management]

scientific article published on 01 July 1990

[Personal experience with VP-16 in the treatment of malignant lymphomas at the Chemotherapy Clinic of the Oncology Center--M. Skłodowskiej-Curie Institute in Warsaw]

artículo científico publicado en 1990

[Preliminary analysis of the Polish lymphoma register: usefulness of the Kiel classification for clinical characteristics and evaluation of therapeutic results]

artículo científico publicado en 1980

[Therapeutic tactics in non-Hodgkin lymphoma. II. Chemotherapy]

artículo científico publicado en 1980

miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda